Prosight Management as of Sept. 30, 2021
Portfolio Holdings for Prosight Management
Prosight Management holds 43 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena Corp SHS (PRTA) | 12.7 | $23M | 323k | 71.23 | |
| Albireo Pharma | 7.6 | $14M | 445k | 31.20 | |
| Galapagos Nv Spon Adr (GLPG) | 7.3 | $13M | 251k | 52.61 | |
| Cue Biopharma (CUE) | 5.3 | $9.5M | 655k | 14.57 | |
| Arena Pharmaceuticals Com New | 5.0 | $9.1M | 153k | 59.55 | |
| Zogenix Com New | 4.1 | $7.5M | 491k | 15.19 | |
| Iovance Biotherapeutics (IOVA) | 3.7 | $6.8M | 275k | 24.66 | |
| Aldeyra Therapeutics (ALDX) | 3.6 | $6.5M | 735k | 8.78 | |
| Convey Hldg Parent | 3.4 | $6.2M | 738k | 8.40 | |
| Exicure | 3.4 | $6.2M | 5.1M | 1.20 | |
| Kezar Life Sciences (KZR) | 3.0 | $5.4M | 630k | 8.64 | |
| Galapagos Nv Call Call Option | 2.9 | $5.3M | 100k | 52.61 | |
| Kalvista Pharmaceuticals (KALV) | 2.5 | $4.5M | 257k | 17.45 | |
| Accolade (ACCD) | 2.3 | $4.1M | 98k | 42.17 | |
| Morphic Hldg (MORF) | 2.2 | $4.0M | 70k | 56.64 | |
| Metacrine Ord | 2.2 | $3.9M | 1.1M | 3.43 | |
| Meiragtx Holdings (MGTX) | 2.1 | $3.8M | 291k | 13.18 | |
| Humana (HUM) | 1.9 | $3.5M | 9.0k | 389.11 | |
| Shattuck Labs (STTK) | 1.9 | $3.4M | 169k | 20.38 | |
| Oscar Health Cl A (OSCR) | 1.8 | $3.3M | 188k | 17.39 | |
| Progyny Put Put Option | 1.7 | $3.1M | 55k | 56.00 | |
| Amedisys (AMED) | 1.6 | $3.0M | 20k | 149.10 | |
| Agilon Health (AGL) | 1.6 | $2.9M | 110k | 26.21 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.5 | $2.7M | 15k | 181.40 | |
| Haemonetics Corporation (HAE) | 1.5 | $2.7M | 38k | 70.59 | |
| Abbvie (ABBV) | 1.5 | $2.7M | 25k | 107.86 | |
| Iovance Biotherapeutics Call Call Option | 1.4 | $2.5M | 100k | 24.66 | |
| Encompass Health Corp (EHC) | 1.3 | $2.4M | 32k | 75.05 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 1.3 | $2.4M | 282k | 8.37 | |
| Irhythm Technologies (IRTC) | 1.2 | $2.2M | 37k | 58.56 | |
| Zimmer Holdings (ZBH) | 1.0 | $1.9M | 13k | 146.38 | |
| Panacea Acquisition Corp Ii Cl A Shs | 1.0 | $1.8M | 189k | 9.77 | |
| Waters Corporation (WAT) | 0.8 | $1.4M | 4.0k | 357.25 | |
| UnitedHealth (UNH) | 0.7 | $1.3M | 3.3k | 390.61 | |
| Cellectis S A Spon Ads (CLLS) | 0.6 | $1.1M | 87k | 12.61 | |
| Sio Gene Therapies Common | 0.6 | $1.1M | 493k | 2.17 | |
| Assembly Biosciences | 0.5 | $924k | 266k | 3.48 | |
| Alector (ALEC) | 0.3 | $625k | 27k | 22.83 | |
| Lifestance Health Group (LFST) | 0.3 | $562k | 39k | 14.49 | |
| Organogenesis Hldgs (ORGO) | 0.3 | $541k | 38k | 14.24 | |
| Oncorus | 0.3 | $518k | 55k | 9.35 | |
| MiMedx (MDXG) | 0.1 | $268k | 44k | 6.06 | |
| Aptose Biosciences Com New | 0.1 | $154k | 71k | 2.18 |
